AMS HP eNews 30 July 2015



  Australasian Menopause Society  
Health Professionals eNews
30 July 2015

Welcome to AMS HP eNews for doctors and other healthcare professionals who have a special interest in women's health. The content covers information and resources relevant to menopause, midlife and the promotion of healthy ageing.


AMS Congress 2015 Canberra - register now and save

AMS Congress 2015


Get involved in the AMS Canberra Congress "Menopause – Mind over Matter" and join us to hear from expert leaders in an exciting scientific program in a city which offers remarkable places to see and things to do.


Register here. 


Remember for AMS Members, special registration rate applies.


Dr Linda Welberry
Congress Chair



Survey – AMS welcomes your feedback

AMS SurveyThis survey should take no more than ten minutes and will help the society plan the education and Congress activities for 2015 and beyond.


Participation is voluntary and any questions regarding the survey may be directed to

Dr Susan Jenner
Australasian Menopause Society 


Go to the survey  


Updated Info Sheet: The Role of Serms after Menopause 

The Role of SERMs after MenopauseSERMs is the shorthand term for a class of drug called selective oestrogen receptor modulators. These compounds are also referred to as oestrogen agonist/antagonists.


They are a versatile group of drugs that can be used to treat a number of conditions associated with aging such as osteoporosis and hormone responsive cancers, and also infertility.

The AMS Information Sheet The Role of SERMS after Menopause has now been updated to help provide relevant details.




Effects of a High vs Moderate Volume of Aerobic Exercise on Adiposity Outcomes in Postmenopausal Women  

This study was aimed at assessing whether hearing decline correlates with menopause and/or cortisol blood levels.


A prospective individual longitudinal study of perimenopausal women followed for 10 years was performed at baseline, and after 2, 7 and 10 years, respectively. With a starting age of around 51 years, 100 women remained in the study after 10 years.


Pure-tone audiometry and cortisol blood testing were performed at all visits. A continuous hearing decline, at all frequencies, was found during the follow-up time.


The rate of decline during the menopausal period was higher than compared with reference materials for the same age group. 



Healthy Bones Action week 3-9 August   

Healthy Bones Action week 3-9 August  Healthy Bones Action Week (formerly National Healthy Bones Week) has been encouraging people of all ages to protect their bones since its inception in 1994.


Healthy Bones Action Week will be celebrated across the country on 3-9 August 2015 to highlight osteoporosis which is one of the least-discussed, under-diagnosed and under-treated diseases in Australia.


Poor bone health affects 2 in 3 Australians over 50 years, including a growing number of men.


Their website has relevant information based on age group in the Why Strong Bones section, as well as a competion for The Fit, Fab & 50 Challenge. Healthy Bones Action Week calls on Australians of all ages to take the three actions to build and maintain healthy bones:

1. Increase daily serves of calcium through milk, cheese or yoghurt;

2. Go for a walk or committing to some new form of regular exercise; and

3. Spend time outdoors to get more vitamin D.  



ANZVS Clinical Update Meeting and Sexual Health Workshop and AMS Menopause Workshop  

ANZVS Clinical Update Meeting and Sexual Health Workshop and AMS Menopause Workshop

This update meeting will be held over two days, 14 and 15 August 2015 at the Double Tree Hilton, Alice Springs, NT.


Program includes: 
  • Lichen Sclerosus
  • Lichen Planus & Plasma Cell Vulvitis
  • Dermatitis Vulva & Lichen Simplex Chronicus
  • Vulval Pain 
  • VIN 
  • AIN
  • Recurrent Vulvovaginal Candidiasis
  • Granuloma Inguinale, Lymphogranuloma Venereum & Chancroid
  • Aphthosis, Hidradenitis Suppurativa & Psoriasis
  • Clinicopathological session

The AMS will provide a Menopause Essentials Update led by Dr Anna Fenton, AMS President and Dr Jane Elliott, AMS Past President. This workshop will focus on the latest evidence-based information on the management of menopause:

  • Menopause: What is it?
  • HRT: Risks and benefits
  • How to manage menopause
  • Low libido and testosterone

See registration brochure for more details.



Join AMS for Member's only content

See exclusive commentary on studies such as:  


Adverse long-term health outcomes associated with premature or early menopause 
Most women experience menopause between the ages of 45 and 55 years. However, 5% of women will go through menopause early, between the ages of 40 and 45 years, and 1% of women become menopausal prematurely, before the age of 40 years [1]. The causes of premature or early menopause are multiple and range from the most common, bilateral oophorectomy, to more rare causes such as genetic, autoimmune, or infectious etiologies. There are multiple adverse long-term health consequences associated with premature or early menopause, including increased risk of dementia, parkinsonism, glaucoma, depression, anxiety, osteoporosis, coronary heart disease, heart failure, sexual dysfunction, and early death. Replacing estrogen mitigates some of these risks, although it may not completely protect against the increased risk of parkinsonism, glaucoma, mood disorders, and sexual dysfunction.

Members read more...  


White matter hyperintensities, hot flushes and estrogen – are they related?
White matter hyperintensities (WMH) observed in the aging brain are associated with small-vessel disease. WMH are detected by brain magnetic resonance imaging (MRI), appearing as hyperintensities on T2-weighted images [1]. The association of such radiological findings and hot flushes has been investigated by Thurston and colleagues [2]. Twenty midlife women (aged 40–60 years) without clinical cardiovascular disease, with an intact uterus and ovaries, and not taking hormone therapy underwent 24 h of ambulatory physiologic and diary hot-flush monitoring to quantify hot flushes. MRI to assess WMH burden, 72 h of actigraphy to quantify sleep, and a blood draw, questionnaires, and physical measures to quantify demographics and cardiovascular risk factors were part of the study protocol as well. Results indicated that more physiologically monitored hot flushes during sleep were associated with greater WMH, controlling for age, race, and body mass index (β [SE] = 0.0002 [0.0001], p = 0.03]. Findings persisted after controlling for sleep characteristics and additional cardiovascular risk factors. No relationships were observed for self-reported hot flushes. 

Members read more...  



AMS 2015 Congress - Mind over Matter

  Australasian Menopause Society
PO Box 264, East Melbourne Vic 8002
Tel: +61 3 9428 8738

  Join the Australasian Menopause Society  
Forward this email to a friend